noema-pharma
(2)
Luigi Costa and the art of starting again
Luigi Costa spent decades building international businesses before co-founding Noema Pharma. His career held an Oslo listing, a public reckoning, a return to the founder’s chair - and a passion for motorcycles that followed him beyond the boardroom.
Ilise Lombardo
Ilise Lombardo is the CEO of Noema Pharma, a Basel-based clinical-stage biotech advancing treatments for central nervous system disorders. A Yale-trained psychiatrist with a Cambridge M.Phil and a Brown degree, she spent two decades in clinical practice and academia before co-founding Arvelle Therapeutics, which sold to Angelini Pharma for roughly $1 billion in 2021. She now steers Noema's pipeline of Phase 2 programs targeting Tourette syndrome, trigeminal neuralgia, tuberous sclerosis seizures and menopause-related CNS symptoms.